Emerging biologics and inhibitors of complement activation pathways, combined with diagnostic advances and orphan drug initiatives, are driving growth in the Cold Agglutinin Disease treatment market globally. https://www.datamintelligence.com/research-report/cold-agglutinin-disease-treatment-market